[18F]ABBV-965i

N/A

Report date: 2026/01/19 20:02:34
NME

Base Information

Drug Name[18F]ABBV-965i
Drug Alias Name[18F]ABBV-965i
ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F
Mechanisms of ActionPositron-emission tomography enhancers
TargetsUpdating
Therapy Area/IndicationsSupranuclear Palsy, Progressive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesInvicro Llc
China Registration ClassN/A

Develop Information

Active CompaniesInvicro Llc
Inactive CompaniesN/A
Active IndicationsSupranuclear Palsy, Progressive
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A